Terms ending in 2033
Bayer Pharma Aktiengesellschaft
Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,481,672 | Bicyclically Substituted Uracils and the Use Thereof In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 9,926,305 | Novel Salts In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 9,949,977 | Bicyclically Substituted Uracils and the Use Thereof In force · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Medium confidence | |
| US 9,949,978 | Bicyclically Substituted Uracils and the Use Thereof In force · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Medium confidence | |
| US 10,300,062 | Bicyclically Substituted Uracils and the Use Thereof In force · Low confidence | Bayer Pharma Aktiengesellschaft | In force | Low confidence | |
| US 10,040,866 | Nucleic Acids and Host Cells Expressing Antibodies Capable of Binding to the Coagulation Factor Xia and Uses Thereof In force · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Medium confidence | |
| US 10,221,247 | Antibodies Capable of Binding to the Coagulation Factor Xia and Uses Thereof In force · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Medium confidence | |
| US 11,046,783 | Antibodies Capable of Binding to the Coagulation Factor Xia and Uses Thereof In force · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Medium confidence | |
| US 9,783,614 | Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and uses thereof In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| US 8,981,104 | Novel 5-Aminotetrahydroquinoline-2-Carboxylic Acids and Their Use In force · High confidence | Bayer Pharma Aktiengesellschaft | In force | High confidence | |
| 13 more term ends in 2033 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
21 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.